Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Conditions

Rectal Neoplasms 5Uterine Cervical Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Glioblastoma 3Esophageal Neoplasms 3Breast Neoplasms 3Lung Neoplasms 2Carcinoma, Hepatocellular 2To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Pulmonary Fibrosis 1Prostatic Neoplasms 1Ototoxicity 1Neoplasms 1MSS Metastatic Colorectal Cancer 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Ketosis 1Insulin Resistance 1Hearing Loss 1Glioma 1Germinoma 1Esophageal Squamous Cell Carcinoma 1Cognitive Dysfunction 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1Acquired Immunodeficiency Syndrome 1

Interventions

lithium sulfate 1fasudil 1Radiotherapy 1Population Groups 1Lithium 1Drug Therapy 1Diet, Mediterranean 1Diet, Fat-Restricted 1Chemoradiotherapy 1Anesthesia, General 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Cognitive Dysfunction × Radiotherapy × Clear all
NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Recruiting
250 enrolled

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡